{"version":"1.0","type":"link","title":"Strategic drug sequencing in hepatocellular carcinoma in the era of chemo-diversity: maximizing the therapeutic benefit of lenvatinib.","author_name":"Iwamoto H 외","author_url":"https://prs-insight.online/author/Iwamoto%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/108901","thumbnail_width":1200,"thumbnail_height":630}